Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Vitamin D, fish oil ‘unlikely’ to impact RMD progression
Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.
Patients with IMIDs respond well to third COVID-19 vaccine dose
Most patients with immune-mediated inflammatory diseases who had weakened responses to a standard vaccine series for COVID-19 mounted a serological response to a third dose, according to data published in Arthritis and Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Molecular signature-assisted drug selection may improve results in rheumatoid arthritis
Molecular signature response classifier-assisted rheumatoid arthritis treatment selection may improve real-world results in patients with rheumatoid arthritis, according to data published in Expert Opinion on Biological Therapy.
EULAR: Telehealth useful for disease monitoring; barriers to access exist
Although telehealth can be useful in treating patients with rheumatic diseases, diagnoses should be established in face-to-face visits, according to new EULAR points to consider.
ACR/AAHKS: Decision to withhold drugs before arthroplasty must weigh flare vs infection
Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.
‘Clearly already scared’: Rheumatology providers, patients brace for Roe v. Wade reversal
The news that the Supreme Court may overturn Roe v. Wade sent a shockwave through all corners of the United States.
EULAR: Taper, discontinue glucocorticoids in rheumatoid arthritis as soon as feasible
The 2022 EULAR recommendations for the management of rheumatoid arthritis are largely similar to the 2019 updates, with one point of emphasis being the importance of rapid glucocorticoid reduction and discontinuation.
‘Split’ decision: JAK inhibitors have delivered on only part of their promise
Janus kinase inhibitors have delivered on some, but not all, of the promises that were expected of them upon approval in 2012, a speaker said at EULAR 2022 Congress.
VIDEO: Medical home model could benefit inflammatory disease patients
CLEVELAND —In this video from the Medical Dermatology Therapy Update II meeting, Florian Rieder, MD, discusses how a medical home for inflammatory diseases could benefit patients.
VIDEO: Take comorbidities into consideration with patients with immune-mediated disease
CLEVELAND — In this video, M. Elaine Husni, MD, MPH, stressed the importance of taking into consideration the comorbidities of a patient with immune-mediated disease.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read